Clinical trial issues in weight-loss therapy
Background
Overweight and obesity rates continue to increase nationally, generating significant interest in weight-loss therapies to address both the burden of obesity-associated chronic disease and individual concerns about appearance. Effective obesity therapies also have the potential for off-label use and unintended consequences.
Methods
The behavioral, pharmacologic, and surgical therapies for obesity are reviewed. Clinical trial issues common to chronic disease states and issues specific to obesity trials are examined. Finally, study designs for obesity therapy, including populations, control arms, sample size, and duration of therapy, are discussed.
To access this article, please choose from the options below
PII: S0002-8703(05)00252-8
doi:10.1016/j.ahj.2005.03.006
© 2006 Mosby, Inc. All rights reserved.
